462 results on '"Brandimarte, G."'
Search Results
2. EPASCORE: A new indicator for prescriptive appropriateness of antimicrobials: our experience
3. The “Cristo Re” hospital experience on telerehabilitation for treatment post thyroidectomy neck pain
4. Combined Overview on Diverticular Assessment:a new score for the management of diverticular disease
5. T.07.10 PERFORMANCE OF A MULTI-COMPOUNDS NUTRACEUTICAL FORMULATION IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE
6. P530 Azathioprine in the maintenance of steroid-free remission in inflammatory bowel disease patients: efficacy and safety in five years of follow-up
7. The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study
8. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study
9. Assessment of the nutritional status in patients with acute diverticulitis
10. Benchmarking between two different hospitals on health risk management in the covid-19 emergency
11. Predictive value of the “DICA” classification on the outcome of diverticular disease of the colon: an international study: 3.14
12. Predictive value of the ‘DICA’ classification on the outcome of diverticular disease of the colon: 2.14
13. Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease
14. Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohnʼs disease
15. Letter: diverticulosis in inflammatory bowel diseases
16. Expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor α in resected acute colonic diverticulitis
17. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double-blind, randomised, placebo-controlled study
18. Microstructural Effects in Face-Centered-Cubic Alloys after Small Charge Explosions
19. T01.01.14 THE ROLE OF A NON-INVASIVE TEST IN THE MANAGEMENT OF UPPER-GI DISEASES: COMPARISON BETWEEN SEROLOGY AND ENDOSCOPIC FINDINGS IN A SAMPLE OF 3,795 PATIENTS
20. OC.08.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS: AN INTERNATIONAL STUDY
21. T04.01.12 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE SETTING: AN EXPERIENCE IN NORTH – EAST ITALY POPULATION
22. T01.01.24 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: A 8 YEARS POPULATION STUDY IN NORTHERN ITALY
23. T02.01.7 IS HELICOBACTER PYLORI CURE A LONG-LIFE STRATEGY? A 25 YEARS SURVEY ON 693 PATIENTS
24. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY
25. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY
26. T01.02.19 IS IT POSSIBILE TO WITHDRAW PPIS THERAPY IN GERD PATIENTS? A PROSPECTIVE STUDY ON 216 PATIENTS USING A SECOND GENARTION BARRIER DRUG
27. OC.08.6 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE: NON-INVASIVE APPROACH FOR THE FRAMING OF INTESTINAL DISEASES
28. T04.02.15 OCCURRENCE OF DIVERTICULAR DISEASE IN COLORECTAL CANCER SCREENING: A 3-YEAR STUDY ON 2,104 PATIENTS
29. T01.01.16 CORRELATION BETWEEN SERUM GASTRIC BIOMARKERS AND HISTOLOGICAL PICTURES OF H. PYLORI INFECTION AND ATROPHIC GASTRITIS: A POPULATION STUDY ON 1,122 PATIENTS
30. OC.08.4 RISK FACTORS FOR ENDOSCOPIC SEVERITY OF DIVERTICULAR DISEASE OF THE COLON AND ITS OUTCOME: A REAL-LIFE CASE-CONTROL STUDY
31. Mesalazine and/or lactobacillus casei in maintaining remission of symptomatic uncomplicated diverticular disease of the colon: a randomised, double-blind, placebo-controlled study: 4.26
32. Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case–control study
33. Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity
34. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease
35. Azathioprine in the maintainance remission in inflammatory bowel disease patients: 7-year follow up
36. DICA endoscopic classification: 2-year analysis from an international, multicenter prospective study
37. P605 Eight-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
38. Prognostic value of the Diverticular Inflammation and Complication Assessment (DICA) classification
39. The endoscopic spectrum of segmental colitis associated with diverticulosis
40. Effectiveness of the Sorbitol H2 Breath Test in Detecting Histological Damage Among Relatives of Coeliacs
41. P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
42. P.02.29 LONG-TERM EFFICACY OF RIFAXIMIN TO MANAGE THE SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON
43. P.02.25 RISK FACTORS FOR COLONIC DIVERTICULOSIS: A STUDY IN PRIMARY CARE SETTING
44. P.01.31 A COMPARISON OF DIFFERENT TREATMENTS FOR SYMPTOMATIC REFLUX ESOPHAGITIS: A REAL-LIFE STUDY
45. OC.05.6 THE PROGNOSTIC VALUE OF A NEW ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE: DICA (DIVERTICULAR INFLAMMATION AND COMPLICATION ASSESSMENT)
46. OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
47. P543 Seven-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patients
48. Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study
49. Sorbitol H 2-breath test versus anti-endomysium antibodies to assess histological recovery after gluten-free diet in coeliac disease
50. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.